- Home
- RETO vs CLNN Comparison
RETO vs CLNN Comparison
Compare RETO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- CLNN
- Stock Information
- Founded
- RETO 1999
- CLNN 2012
- Country
- RETO China
- CLNN United States
- Employees
- RETO N/A
- CLNN N/A
- Industry
- RETO Multi-Sector Companies
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- RETO Consumer Discretionary
- CLNN Health Care
- Exchange
- RETO Nasdaq
- CLNN Nasdaq
- Market Cap
- RETO 24.7M
- CLNN 23.1M
- IPO Year
- RETO 2017
- CLNN N/A
- Fundamental
- Price
- RETO $2.09
- CLNN $3.82
- Analyst Decision
- RETO
- CLNN Strong Buy
- Analyst Count
- RETO 0
- CLNN 5
- Target Price
- RETO N/A
- CLNN $40.00
- AVG Volume (30 Days)
- RETO 45.8K
- CLNN 70.5K
- Earning Date
- RETO 08-19-2025
- CLNN 08-19-2025
- Dividend Yield
- RETO N/A
- CLNN N/A
- EPS Growth
- RETO N/A
- CLNN N/A
- EPS
- RETO N/A
- CLNN N/A
- Revenue
- RETO $1,828,976.00
- CLNN $350,000.00
- Revenue This Year
- RETO N/A
- CLNN N/A
- Revenue Next Year
- RETO N/A
- CLNN $1,753.57
- P/E Ratio
- RETO N/A
- CLNN N/A
- Revenue Growth
- RETO N/A
- CLNN N/A
- 52 Week Low
- RETO $1.75
- CLNN $2.28
- 52 Week High
- RETO $18.20
- CLNN $6.90
- Technical
- Relative Strength Index (RSI)
- RETO 37.83
- CLNN 55.42
- Support Level
- RETO $2.00
- CLNN $3.30
- Resistance Level
- RETO $2.23
- CLNN $3.93
- Average True Range (ATR)
- RETO 0.20
- CLNN 0.23
- MACD
- RETO -0.01
- CLNN 0.02
- Stochastic Oscillator
- RETO 10.59
- CLNN 82.61
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.